Pharsight

Organon Sub Merck patents expiration

1. Bridion patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE44733 ORGANON SUB MERCK 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
Jan, 2026

(2 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) Jun 25, 2024
M (M) Jan 22, 2024

Drugs and Companies using SUGAMMADEX SODIUM ingredient

Market Authorisation Date: 15 December, 2015

Treatment: Reversal of drug-induced neuromuscular block

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of BRIDION before it's drug patent expiration?
More Information on Dosage

BRIDION family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic